Ray Dalio's MDLN Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 19,847 shares of Medline Inc. (MDLN) worth $782,766, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Ray Dalio has initiated a new position in MDLN, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Medline (MDLN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medline (MDLN) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +19,847 | New Buy | 19,847 | $39.44 |
Ray Dalio's Medline Investment FAQs
Ray Dalio first purchased Medline Inc. (MDLN) in Q2 2026, acquiring 19,847 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Medline Inc. (MDLN) for 1 quarters since Q2 2026.
Ray Dalio's largest addition to Medline Inc. (MDLN) was in Q2 2026, adding 19,847 shares worth $782,766.
According to the latest 13F filing for Q2 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 19,847 shares of Medline Inc. (MDLN), valued at approximately $782,766.
As of the Q2 2026 filing, Medline Inc. (MDLN) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Medline Inc. (MDLN) was 19,847 shares, as reported at the end of Q2 2026.